Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 36, 2002 - Issue 2
Submit an article Journal homepage
30
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Prostate-Specific Antigen for Prostate Cancer Staging in a Population-based Register

G. Sandblom Department of Urology, Faculty of Health Sciences, University Hospital of Linköping, Sweden
,
L. Holmberg Regional Oncological Centre, Uppsala University, Sweden
,
J.-E. Damber Department of Urology, Sahlgrenska Hospital, Gothenburg, Sweden
,
J. Hugosson Department of Urology, Sahlgrenska Hospital, Gothenburg, Sweden
,
J.-E. Johansson Department of Urology and Centre for Assessment of Medical Technology, Örebro Medical Centre, Sweden
,
R. Lundgren Department of Surgery/Section of Urology, Helsingborg Hospital, Sweden
,
E. Mattsson Regional Oncological Centre, Uppsala University, Sweden
,
J. Nilsson Regional Oncological Centre, Uppsala University, Sweden
&
E. Varenhorst Department of Surgery and Urology, Norrköping and Finspång Hospitals, Sweden
 show all
Pages 99-105 | Published online: 09 Jul 2009

  • The National Board of Health and Welfare, Centre for Epidemiology. Cancer incidence in Sweden 1997. Stockholm: Norstedts Tryckeri; 1999.
  • Sandblom G, Dufmats M, Nordenskjo¨ld K, Varenhorst E. Prostate carcinoma trends in three counties in Sweden 1987-1996. Results from a population-based National Cancer Register. Cancer 2000; 88: 1445-53.
  • Blackledge GR, Lowery K. Role of prostate-speci? c antigen as a predictor of outcome in prostate cancer. Prostate Suppl 1994; 5: 34-8.
  • Bjo¨rk T, Lilja H, Christensson A. The prognostic value of different forms of prostate-speci? c antigen and their ratios in patients with prostate cancer. Br J Urol 1999; 84:1021-7.
  • Cohen RJ, Chan WC, Edgar SG, Robinson E, Dodd N, Hoscek S, et al. Prediction of pathological stage and clinical outcome in prostate cancer: an improved preoperative model incorporating biopsy-determined intra-ductal carcinoma. Br J Urol 1998; 81: 413-18.
  • The Royal College of Radiologists‘ Clinical Oncology Information Network British Association of Urological Surgeons. Guidelines on the management of prostate cancer. Br J Urol 1999; 84: 987-1014.
  • Partin AW, Kattan MW, Subong ENP, Walsh PC, Wojno KJ, Oesterling JE, et al. Combination of prostate-speci? c antigen, clinical stage, and Gleason score to predict pathological stage of prostate cancer. JAMA 1997; 277: 1445-51.
  • Narayan P, Fournier G, Gajendran V, Leidich R, Lo R, Wolf JS, et al. Utility of preoperative serum prostate-speci? c antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer. Urology 1994; 44: 519-24.
  • Oesterling JE, Martin SK, Bergstrahl EJ, Lowe FC. The use of prostate-speci? c antigen in staging patients with newly diagnosed prostate cancer. JAMA 1993; 269: 57-60.
  • Rydh A, Tomic R, Tavelin B, Hietala SO, Damber JE. Predictive value of prostate-speci? c antigen, tumour stage and tumour grade for the outcome of bone scintigraphy in patients with newly diagnosed prostate cancer. Scand J Urol Nephrol 1999; 33: 89-93.
  • Chybowski FM, Larson Keller JL, Bergstrahl EJ, Oesterling JE. Predicting radionuclide bone scan ? ndings in patients with newly diagnosed, untreated prostate cancer: prostate speci? c antigen is superior to all other clinical parameters. J Urol 1991; 145: 313-18.
  • Bruwer G, Heyns CF, Allen FJ. In? uence of local tumour stage and grade on reliability of serum prostate-speci? c antigen in predicting skeletal metastases in patients with adenocarcinoma of the prostate. Eur Urol 1999; 35: 223-7.
  • Mattsson B. The completeness of registration in the Swedish Cancer Registry. Stockholm: Stat Rep HS; Report No. 15, 1977.
  • Sandblom G, Mattsson E, Nilsson J, Damber JE, Johansson JE, Lundgren R, et al. Prostate cancer registration in four Swedish regions 1996. Differences in incidence, age structure and management. Scand J Urol Nephrol 1999; 33: 306-11.
  • UICC (Union Internationale Contre le Cancer). TNM classi? cation of malignant tumours, ed. 4. Geneva: International Union Against Cancer; 1992.
  • Stamey TA. Progress in standardization of immunoas-says for prostate-speci? c antigen. Urol Clin N Am 1997; 24:269-73.
  • Stamey TA, Zuxiong C, Prestigiacomo AF. Reference material for PSA: the IFCC standardization study. Clin Biochem 1998; 31: 475-81.
  • Jaeschke R, Guyatt GH, Sackett DL. Users‘ guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients. JAMA 1994; 271: 703-7.
  • Schwartz LH, LaTrenta LR, Bonaccio E, Kelly WK, Scher HI, Panicek DM. Small cell and anaplastic prostate cancer: correlation between CT ? ndings and prostate-speci? c antigen level. Radiology 1998; 208: 735-8.
  • Begg CB. Biases in the assessment of diagnostic tests. Statistics in Medicine 1987; 6: 411-23.
  • Wieder JA, Soloway. Incidence, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. J Urol 1998; 160: 299-315.
  • Pedersen KV, Herder A. Radical retropubic prostatectomy for localized prostatic carcinoma: a clinical and pathological study of 201 cases. Scand J Urol Nephrol 1993;27:219-24.
  • Mukamel E, de Kernion JB, Dorey F, Hannah J. Signi? cance of histological prognostic indicators in patients with carcinoma of the prostate. Br J Urol 1990;65:46-50.
  • Meng MV, Carroll PR. When is pelvic lymph node dissection necessary before radical prostatectomy? A decision analysis. J Urol 2000; 164: 1235-40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.